國立虎尾科技大學 |

Personalized Medicine as Innovation = What Can Germany Learn from the USA /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Personalized Medicine as Innovation/ by Katharina Kichko.
Reminder of title:	What Can Germany Learn from the USA /
Author:	Kichko, Katharina.
Description:	XXV, 354 p. 29 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Health economics. -
Online resource:	https://doi.org/10.1007/978-3-658-27843-4
ISBN:	9783658278434

Personalized Medicine as Innovation = What Can Germany Learn from the USA /
Kichko, Katharina.

Personalized Medicine as InnovationWhat Can Germany Learn from the USA /[electronic resource] :by Katharina Kichko. - 1st ed. 2019. - XXV, 354 p. 29 illus.online resource. - Gesundheitsmanagement und Gesundheitsökonomik,2523-7667. - Gesundheitsmanagement und Gesundheitsökonomik,.

Personalized Medicine Background -- The United States of America as Early Knower -- Germany as Follower -- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.

Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future. Contents Personalized Medicine Background The United States of America as Early Knower Germany as Follower Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S. Target Groups Students and lecturers in health management Practitioners in the field of healthcare About the Author Katharina Kichko has written this book within her PhD program at the University of Greifswald.

ISBN: 9783658278434

Standard No.: 10.1007/978-3-658-27843-4doiSubjects--Topical Terms:

810102
Health economics.

LC Class. No.: RA410-410.9

Dewey Class. No.: 338.473621

Personalized Medicine as Innovation = What Can Germany Learn from the USA /
LDR:02601nam a22003975i 4500 001 1012378
003 DE-He213
005 20200706211041.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783658278434 $9 978-3-658-27843-4
024 7 $a 10.1007/978-3-658-27843-4 $2 doi
035 $a 978-3-658-27843-4
050 4 $a RA410-410.9
072 7 $a KCQ $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KCVJ $2 thema
082 0 4 $a 338.473621 $2 23
100 1 $a Kichko, Katharina. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1306631
245 1 0 $a Personalized Medicine as Innovation $h [electronic resource] : $b What Can Germany Learn from the USA / $c by Katharina Kichko.
250 $a 1st ed. 2019.
264 1 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer Gabler, $c 2019.
300 $a XXV, 354 p. 29 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Gesundheitsmanagement und Gesundheitsökonomik, $x 2523-7667
505 0 $a Personalized Medicine Background -- The United States of America as Early Knower -- Germany as Follower -- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.
520 $a Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future. Contents Personalized Medicine Background The United States of America as Early Knower Germany as Follower Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S. Target Groups Students and lecturers in health management Practitioners in the field of healthcare About the Author Katharina Kichko has written this book within her PhD program at the University of Greifswald.
650 0 $a Health economics. $2 bicssc $3 810102
650 0 $a Public health. $3 560998
650 0 $a Management. $3 558618
650 0 $a Industrial management. $3 556510
650 1 4 $a Health Economics. $3 786205
650 2 4 $a Public Health. $3 592982
650 2 4 $a Innovation/Technology Management. $3 786196
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783658278427
776 0 8 $i Printed edition: $z 9783658278441
830 0 $a Gesundheitsmanagement und Gesundheitsökonomik, $x 2523-7667 $3 1279398
856 4 0 $u https://doi.org/10.1007/978-3-658-27843-4
912 $a ZDB-2-ECF
912 $a ZDB-2-SXEF
950 $a Economics and Finance (SpringerNature-41170)
950 $a Economics and Finance (R0) (SpringerNature-43720)